Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC)
Clinical trial NCT02402764 · COMPLETED
Trial details
- NCT number
- NCT02402764
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-08
- Primary completion
- 2016-03-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.